As of 2024-10-13, the Relative Valuation of Oramed Pharmaceuticals Inc (ORMP) is 2.43 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.38 USD, the upside of Oramed Pharmaceuticals Inc based on Relative Valuation is 2.1%.
The range of the Relative Valuation is 0.75 - 5.22 USD.
| Range | Selected | |
| Trailing P/E multiples | 4.7x - 10.2x | 7.4x |
| Forward P/E multiples | 14.7x - 26.3x | 20.5x |
| Fair Price | 0.75 - 5.22 | 2.43 |
| Upside | -68.5% - 119.3% | 2.1% |
| Date | P/E |
| 2024-10-11 | 4.65 |
| 2024-10-10 | 4.64 |
| 2024-10-09 | 4.69 |
| 2024-10-08 | 4.55 |
| 2024-10-07 | 4.71 |
| 2024-10-04 | 4.59 |
| 2024-10-03 | 4.71 |
| 2024-10-02 | 4.67 |
| 2024-10-01 | 4.69 |
| 2024-09-30 | 4.77 |
| 2024-09-27 | 4.85 |
| 2024-09-26 | 4.69 |
| 2024-09-25 | 4.67 |
| 2024-09-24 | 4.59 |
| 2024-09-23 | 4.54 |
| 2024-09-20 | 4.51 |
| 2024-09-19 | 4.83 |
| 2024-09-18 | 4.73 |
| 2024-09-17 | 4.90 |
| 2024-09-16 | 4.85 |
| 2024-09-13 | 4.87 |
| 2024-09-12 | 4.61 |
| 2024-09-11 | 4.65 |
| 2024-09-10 | 4.69 |
| 2024-09-09 | 4.71 |
| 2024-09-06 | 4.59 |
| 2024-09-05 | 4.51 |
| 2024-09-04 | 4.65 |
| 2024-09-03 | 4.71 |
| 2024-08-30 | 4.67 |
| 2024-08-29 | 4.69 |
| 2024-08-28 | 4.69 |
| 2024-08-27 | 4.67 |
| 2024-08-26 | 4.83 |
| 2024-08-23 | 4.85 |
| 2024-08-22 | 4.83 |
| 2024-08-21 | 4.83 |
| 2024-08-20 | 4.69 |
| 2024-08-19 | 4.63 |
| 2024-08-16 | 4.57 |
| 2024-08-15 | 4.59 |
| 2024-08-14 | 4.38 |
| 2024-08-13 | 4.61 |
| 2024-08-12 | 4.53 |
| 2024-08-09 | 4.57 |
| 2024-08-08 | 4.63 |
| 2024-08-07 | 4.32 |
| 2024-08-06 | 4.59 |
| 2024-08-05 | 4.32 |
| 2024-08-02 | 4.57 |